Implementation of Long-Acting Drugs for Treatment and Prevention of HIV
November 13, 2023
(11:00 AM – 3:45 PM ET)
Be sure to check the course page and agenda regularly for the most up-to-date information.
Course Information
- The IAS–USA
- Course Faculty, IAS–USA Staff, and Scientific Leadership Board Financial Relationship With Commercial Entities
- Claiming CME Credits, ABIM MOC Points, or a Certificate of Participation
- Annotating Electronic Materials for iOS, Android, and Kindle
- The link to the evaluation form for this activity is activated in your IAS–USA account under “My Activities”
- Frequently Asked Questions
Presentation Summaries
- State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV
Presenter: Aadia I. Rana, MD - State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention
Presenter: Colleen Kelley, MP, MPH - Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel
Presenter: Joseph J. Eron, Jr, MD - Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention Strategies
Presenter: Joshua P. Havens, PharmD - Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?
Presenter: Raphael J. Landovitz, MD, MSc
Panelists: Peter L. Anderson PharmD, Kevin L. Ard, MD, MPH, Carolyn Chu, MD, MSc, Joseph J. Eron, Jr, MD, Joshua P. Havens, PharmD, and Aniruddha Hazra, MD
Last Modified: